Cargando…
Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia
There is a paucity of information on the use of novel hormonal agents in Southeast Asian patients. We reviewed the clinical roles of novel hormonal therapy (NHT), namely abiraterone acetate (AA), enzalutamide, apalutamide and darolutamide, in the management of advanced prostate cancer, and data on i...
Autores principales: | Ong, Teng Aik, Saad, Marniza, Lim, Jasmine, Lee, Hsien Hooi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824980/ https://www.ncbi.nlm.nih.gov/pubmed/36609251 http://dx.doi.org/10.1186/s12894-022-01156-8 |
Ejemplares similares
-
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
por: Lim, Jasmine, et al.
Publicado: (2021) -
Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
por: Lim, Jasmine, et al.
Publicado: (2020) -
Efficacy and safety of therapies for advanced prostate cancer in
Asia: Evidence from a systematic literature review
por: Saad, Marniza, et al.
Publicado: (2022) -
Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
por: Chiong, Edmund, et al.
Publicado: (2022) -
Analgesic Prescription Patterns and Pain Outcomes in Southeast Asia: Findings From the Analgesic Treatment of Cancer Pain in Southeast Asia Study
por: Thinh, Dang Huy Quoc, et al.
Publicado: (2017)